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http://dx.doi.org/10Background and Aims. Leukoaraiosis (LA), one of the most frequent causes of an age-
associated cognitive decline, can be associated with a poor quality of life, leading overall
to far-reaching public health problems. Chronic hypoxia of the white matter of the brain
may be a factor triggering this entity. LA may develop as a consequence of chronically
insufficient cellular energy production and the accumulation of free radicals.
Methods. In this context, after hypothesizing that the number of healthy mitochondria
can be crucial in this complex process, a case-control LA study was carried out in which
we analyzed the numbers of deleted and non-deleted mitochondria (the common D-loop
deletion) per white blood cell. A total of 234 patients with LA and 123 MRI alteration-
free subjects served as a control group.
Results. Interestingly, it emerged that the ratio of deleted relative to non-deleted mito-
chondria is strongly associated with the risk of LA. The calculated K ratio in the LA
group was significantly lower than the K ratio in the controls (LA: K 0.37 95% CI
0.05; controls: K 0.48, 95% CI 0.076, p ! 0.001).
Conclusions. Our study suggests that the ratio of the dmDNA and mDNA can be of great
importance in the pathogenesis of LA.  2015 IMSS. Published by Elsevier Inc.
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Leukoaraiosis (LA) is originally a neuroimaging term and
refers to hypodensities in CT scans and hyper-intense sig-
nals in T2-weighed MRI scans. Although LA is a neuroi-
maging term, it relates to a complex clinical entity (1e3).
LA has been reported to be associated with a cognitive
decline and a slowing of mental processing, which can be
manifested as a slowness of speech or understanding
(4e6). LA is considered to be a vascular demyelinating
process (7,8). Although it results from factors such as aging
and hypertension (9), development of LA may betributed equally to the work.
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factors (10e15).
These genetic and other risk factors suggest that chronic
hypoxia might trigger intracellular biochemical events,
which result in LA (16,17). Accordingly, we hypothesized
that a key role in the demyelinization process of LA may
be played by chronically insufficient energy production
(18). Hence, in addition to certain biochemical features,
the number of mitochondria, the main energy-supplying or-
ganelles in mammalian cells (19), may be deterministic for
the fate of neurons and glia cells. Mitochondrial mutations
can affect different cell types in different ways; this is re-
flected in mitochondria-associated genetic disorders such
as MELAS (20). In such cases, mutations of the mitochon-
drial DNA or tRNA bring about a malfunction in the
affected mitochondria (21). However, virtually no data are
available as concerns the number of the mitochondriaInc.
iversity from ClinicalKey.com by Elsevier on March 21, 2019.
 Copyright ©2019. Elsevier Inc. All rights reserved.
605Reduced Number of Mitochondria in Leukoaraiosisthemselves, which must be an important feature from an en-
ergetic aspect.
Although the numbers of mitochondria are probably
essential as concerns the neurons and glia cells (17), these
data cannot easily be examined in clinical studies. Howev-
er, the numbers of mitochondria in other tissues, which are
functionally in constant contact with the brain tissue, may
be informative. The white blood cells, for example,
constantly circulate and communicate with the brain tissue.
Their energy store may be important for the maintenance of
the brain because they act as free radical scavengers and
also check on the integrity of the neurovascular system of
the brain (22). The white blood cells, vascular cells and
brain tissue most likely behave as a functional unit. Howev-
er, very few data have been published as regards the
numbers of mitochondria among the different cell types.
The number of mitochondria in the white blood cells may
be an indicator of the overall number of mitochondria in
the given individual.
In this context, we examined whether there is an associ-
ation between the number of mitochondria in the white
blood cells and the development of LA. Besides the genetic
heterogeneity of the mitochondrial DNA (23), there are two
large types of mitochondrial DNA: one with D-loop se-
quences and one without them. The former is known as
mitochondrial DNA (mDNA) and the latter as mitochon-
drial DNA with a large and common deletion of 123-
1256 bp (dmDNA). This latter DNA might be considered
to malfunction in some way (24,25). In our present study
we identified the copy number per white blood cell for both
mDNA and dmDNA.Patients and Methods
Study Population
A total of 234 patients with LA were recruited after a clin-
ical scrutiny. LA was diagnosed on the basis of MRI scans
as described previously (14). Patients with degrees of I or II
on the validated Fazekas LA scale (26) were excluded as
were patients with clinical entities such as multiple scle-
rosis, trauma, postinfectious demyelination, radiationTable 1. Sequences and concentrations of primers and probes
Primer Sequence
GAPDH for 50-TCC AGT ATG ATT CCA CCC ATG GCA-3
GAPDH rev 50-TTC TAC ATG GTG GTG AAG ACG CCA-
GAPDH probe 50-TTC CAT GGC ACC ATC AAG GCT GAG A
mtDNA for 50-ATG GCC AAC CTC CTA CTC CTC ATT-30
mtDNA rev 50-TTA TGG CGT CAG CGA AGG GTT GTA-3
mtDNA probe 50-CGC AAT GGC ATT CCT AAT GCT TAC C
dmtDNA for 50-ACA CAA ACT ACC ACC TTT GGC AGC-
dmtDNA rev 50-TTC GAG TGC TAT AGG CGC TTG TCA-3
dmtDNA probe 50-CCA AAG ACC ACA TCA TCG AAA CCG
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koencephalopathy because these did not result from
vascular and chronic hypoxia-triggered demyelination.
The patient group consisted of 234 subjects with LA
defined as irregular periventricular hyperintensities extend-
ing into the deep white matter in T2-weighted MRI scans
(grade 3 periventricular hyperintensities) and deep white
matter hyperintensive signals with beginning confluence
of the foci or with large confluent areas in the
T2-weighed MRI scans (deep white matter hyperintensive
grade 2e3 signals).
One hundred twenty three MRI alteration-free subjects
with no neurological complaints recruited from a popula-
tion pool in our regional register served as a control group.
The clinical risk factors, defined as described in an earlier
leukoaraiosis study (27), and basic psychological data were
registered in the controls.
DNA Isolation
Genomic DNA was extracted from 200 ml of peripheral
blood anticoagulated with EDTA. The leukocyte DNA
was isolated by a desalting method (28) and was stored at
20C until further use.
Determination of Absolute Number of Mitochondria per
Leukocyte
The TaqMan real-time PCR assays, specific for the ampli-
fication of mDNA and dmDNA, were established by using
a specific set of primers and probes. Quantitative mDNA
and dmDNA amplification data were normalized to
GAPDH as an internal reference gene, which was co-
amplified simultaneously in a single-tube assay. The
primers were obtained from Sigma-Aldrich (St. Louis,
MO) and the sequences are listed in Table 1. Thermal
cycling was performed on the Bio-Rad CFX96 real-time
PCR system (Bio-Rad, Hercules, CA). Amplification reac-
tions (10 ml each) were performed in duplicate with 1 ml of
template DNA. The amplification mix contained the
following ingredients: 5 ml of iQ Multiplex Powermix
(Bio-Rad), 0.4 ml of each primer, 0.1 ml of each fluorogenic
probe, and 1 ml of sample DNA in a total volume of 10 mlTaqMan signal dyes Conc. (mmol)
0 - 0.4
30 - 0.4
A-30 ROX/BHQ2 0.2
- 0.4
0 - 0.4
G-30 HEX/TAMRA 0.1
30 - 0.4
0 - 0.4
CA-30 FAM/TAMRA 0.1
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Table 2. Characteristics of patients and control subjects
Characteristics Leukoaraiosis n [ 234 Controls n [ 123
Sex (females, males) 123, 111 65, 58
Age, years 71.6  10.8a 59.4  8.62
BMI, kg/m2 24.6  2.33 24.4  3.42
Cholesterol, mmol 5.91  1.24 5.52  1.56
Triglycerides, mmol 1.48  0.91 1.50  0.82
Hypertension 46.6%a 22.0%
Diabetes mellitus 17.9%a 4.88%
Smokers 29.9% 28.5%
Drinkers 12.0% 9.0%
ap ! 0.05; the leukoaraiosis group was compared with the control group
by means of the c2 test or Mann-Whitney test.
606 Szolnoki et al./ Archives of Medical Research 46 (2015) 604e608per single-tube reaction. The assay conditions were 3 min at
95C and 44 cycles of 95C for 10 sec and 60C for 45 sec.
Quantification was evaluated by the comparative CT
(threshold cycle) method (29).
Because no data were available concerning the stability
of the number of mitochondria in white blood cells, the
numbers of mitochondria in five patients and five controls
were determined three times with a minimum interval of
1 month between blood drawings in the same subject. We
found merely minimal number differences between the
different blood samples in the same subject (data not
shown).
Statistical Analysis
Clinical variables in the LA and control groups are listed
and compared statistically in Table 2.
mDNA and dmDNA contents per white blood cell in the
LA group were compared with those in the control group by
means of the two-paired T-test (Table 3). In order to make
the comparison biologically more sensitive, the mathemat-
ical difference between the mDNA and mdDNA contents
per cell were derived by the sum of mDNA and dmDNATable 3. Distributions of deleted and non-deleted mitochondrial DNA
contents per cell in the leukoaraiosis and control groups
Genotypes
Leukoaraiosis n [ 234
Controls n [ 123(mean ± 2 SD)
Number of non-deleted
mitochondria per cell
5.5  0.45 5.4  0.5
Number of deleted
mitochondria per cell
3.45  0.5 3.5  0.5
Ka 0.37  0.03 0.48  0.03b
aNon-deleted mitochondrial DNA content per cell minus deleted
mitochondrial DNA content per cell divided by the sum of the contents
of deleted and non-deleted mitochondrial DNA per cell
(K 5 [mDNA  dmDNA]/[mDNA þ dmDNA]).
bp! 0.001: the leukoaraiosis group was compared with the control group
by means of the two-paired t-test.
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tio (K) indicated the weight of uncompensated dmDNA per
cell:
K5
ðmDNA content  dmDNA contentÞ
ðmDNA content þ dmDNA contentÞ :
K values for each of the LA patients and the controls were
compared statistically between the LA and control groups
by means of the two-paired T-test (Table 3).
Univariate statistical analysis was followed by a logistic
regression comparison involving the age, hypertension and
diabetes mellitus (due to the statistical difference between
the LA and control groups) in addition to the calculated
values of K.Results
The frequency of hypertension in the LA group was higher
than that in the controls (Table 2). mDNA and dmDNA con-
tent did not differ statistically between the LA and control
groups (Table 3).
The calculated value of K for the LA group was signif-
icantly lower than that for the controls after the used logis-
tic regression analysis. This logistic regression analysis was
carried out for the differences between the LA and controls
with regards to the age, hypertension and diabetes mellitus.
In this way, we could diminish the confounding effects of
these clinical factors because they could also be associated
with the reduced number of mitochondria (LA: K 0.37,
95% CI 0.05; controls: K 0.48, 95% CI 0.076; p! 0.001).Discussion
Although the basic mDNA and dmDNA contents were sta-
tistically the same in the LA and control groups, the value
of K was significantly lower for the LA group than that for
the control group. This was a mathematical indicator of a
larger proportion of dmDNA. dmDNA can potentially
result in a mitochondrial malfunction in the following
ways: (a) lower energy production; (b) a lower free radical
scavenging capacity; (c) a lower rate of adaptation to the
prevailing demand for energy production; (d) a narrower
range in the adjustment to the prevailing energy demand;
(e) a lower of metabolic function capacity in general; (f)
a larger extent of free radical production; and (g) a general
malfunction of the mitochondrial genetic regulation.
No genetic and biochemical data are available to suggest
which of these postulated mechanisms actually exist, but a
lower and narrower energy capacity appears probable as the
main pathomechanism behind LA. It was demonstrated
earlier at a molecular level that LA can result from a very
slight, but chronic, level of hypoxia, which can be caused
by various environmental and genetic susceptibility factorsiversity from ClinicalKey.com by Elsevier on March 21, 2019.
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findings that uncoupling protein genetic variants play roles
in the development of LA (30). The uncoupling proteins
govern the electrochemical gradient between the inner
and outer spaces of the mitochondria (31), this gradient be-
ing essential for the energy production of the mitochondria.
If dmDNA is associated with any kind of biochemical mal-
function, an uncompensated and larger proportion of
dmDNA in the cells can be unfavorable from an energetic
aspect.
Our results revealed that the lower the difference be-
tween the contents of mDNA (which compensates malfunc-
tions of the dmDNA) and dmDNA the larger the risk of LA
in the given individual.
In conclusion, our study suggests that the ratio of
dmDNA and mDNA contents can be of great importance
in the pathogenesis of LA. These results indicate the need
for new approaches for examination of mitochondrial con-
tents in other common brain disorders.
Study Limitations
The numbers of mitochondria in the affected brain tissues
could not be examined because this was a clinical study
carried out in a human patient population. Brain biopsies
would not have been ethical; thus, it remained to identify
associations between the numbers of mitochondria in
different human tissues. Although we found no apparent
change in the number of mitochondria in a small cohort
of study subjects during several weeks (which involved
several turnovers of the mitochondria in the white blood
cells), insufficient scientific data are available concerning
the stability of the numbers of mitochondria in the different
tissues. This should be clarified.
No examinations were carried out in this study to iden-
tify the features of the malfunctioning of the mitochondria
with deletion DNAs. However, these limitations do not
greatly affect the present results because they are not obvi-
ously associated with the findings. Moreover, these postu-
lated limitations are rather scientific questions, which
should be considered in subsequent examinations.
Albeit the logistic regression statistical method has
greatly decreased the confounding effects of the clinical
factors such as age, hypertension (32,33) and diabetes mel-
litus (34), the results need to be confirmed by a larger pop-
ulation study.References
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